- Pfizer’s PCV 13 vaccine selected for inclusion in expansion of India’s immunization program. Phase 1 immunization program to cover 20% of around 26 million children [1] of India’s birth cohort under the Gavi funded program
[2]
PneumoNET, PIDOPS and ASIP studies
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.